Kamikihito improves cancer ‐related fatigue in castration‐resistant prostate cancer patients receiving enzalutamide: Multidimensional approach including metabolomics analysis

ConclusionKamikihito corrected the abnormalities in lipid metabolism, which may have improved the production of amino acids, leading to reduced CRF in CRPC patients receiving enzalutamide.

Source: Traditional and Kampo Medicine - September 16, 2021 Category: Complementary Medicine Authors: Satoshi Tamada, Taro Iguchi, Minoru Kato, Takeshi Yamasaki, Naoko Tsuchiya, Katsuya Ohbuchi, Chika Shimobori, Junzo Nojima, Sayaka Yasuda, Kyoko Ebisu, Yasuyoshi Watanabe Tags: ORIGINAL ARTICLE Source Type: research